Form 4 for SRPT Sarepta Therapeutics, Inc.
Accepted 2024-05-06 00:00:00 ET · period of report 2024-05-02 · accession 0000950170-24-053837 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2024-05-06 | 2024-05-02 | SRPT | Murray Dallan | Chief Customer Off | S - Sale | $140.00 | -3,635 | 18.1K | -17% | -$508.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-02 | S | D | 3,635 | $140.00 | 18,125 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024. |